Highlight
Metabolomics in functional foods – A powerful complement to randomized clinical trials
Functional foods are foods or dietary ingredients that provide a health benefit beyond basic nutrition. A new legislation, known as the Nutrition and Health Claims Regulation, defines the legal framework for such claims within the European Union. Any claim about the nutritional or physiological effects of a product must be scientifically demonstrated. In this study, we have focused on the exploration of metabolomics as a complementary profiling technology to establish monitoring/data analysis procedures of randomized nutritional trials. More specifically, a combined intake of soybean and grapefruit in a human intervention study was analyzed with respect to both pharmacological and physiological effects. Resulting multivariate models showed a diet-induced decrease of lactate, cholesterols and triglycerides. The most drastically elevated metabolite, myo-inositol, was found to accompany a marked reduction of triglyceride levels. Suggestively, this is due to the biotransformation of myo-inositol to phosphatidylinositol, which results in a decrease of available precursors to form triglycerides. Strong inter-subject ... … Read entire article »
Publications
Diagnostic properties of metabolic perturbations in rheumatoid arthritis
This is the first time that the usefulness of metabolic profiling has been demonstrated in the diagnosis of RA.This study assessed the feasibility of diagnosing early rheumatoid arthritis (RA) by metabolic biomarkers. … Read more »
Serum metabolite signature predicts the acute onset of diabetes in spontaneously diabetic congenic BB rats
The clinical presentation of type 1 diabetes is preceded by a prodrome of beta cell autoimmunity. We probed the short period of subtle metabolic abnormalities, which precede the acute onset of diabetes … Read more »
Metabolomics for monitoring kidney-transplant patients
Kidney transplant provides the only hope for a normal life for patients with end-stage renal disease, i.e.,kidney … Read more »
News and Views
Press release Nature publication
AcureOmics associates participated in a large international project (MAQC-II) aimed to examine and generate ”best practice” protocols in data analysis for predicting clinical endpoints based on gene expression data. … Read more »
Renewed SME status for AcureOmics
AcureOmics AB has renewed its’ status as SME (micro, small and medium-sized enterprizes) with EMA (European Medicines Agency). - The SME status is important for AcureOmics AB and has proven to be key … Read more »
Press release: AcureOmics AB granted millions by EU for metabolic disease project
AcureOmics is taking part in BOLD (Biology of Liver and Pancreatic Development and Disease), a Marie Curie Initial Training Network (ITN) within EU’s FP7 program. The BOLD project aims to provide new … Read more »